BELLUS Health Inc. (TSX:BLU)
Share Price & News Healthcare

Similar Companies

Symbol Title
AND Andlauer Healthcare Group Inc
ACB Aurora Cannabis Inc.
AVNT Avant Brands Inc
BHC Bausch Health Companies Inc.
CGY Calian Group Ltd.
CWEB Charlotte's Web Holdings Inc.
CRON Cronos Group Inc.
DN Delta 9 Cannabis Inc.
EXE Extendicare Inc.

Analyst Recommendation


Company Overview: BELLUS Health Inc. (TO: BLU) is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. In August 2019, the company appointed Dr. Bonuccelli as the Chief Medical Officer, who has more than 20 years of significant expertise in clinical development of respiratory products.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions